Enlivex is the first and only stock that provides investors with exposure to prediction markets, through a treasury strategy focused on the most exciting prediction markets protocol, Rain.
In addition, the company has an operating business focused on late-stage clinical development of Allocetra™, a novel therapy designed to treat the joint disease osteoarthritis.